Search for: "State v. Tri-State Pharmaceutical" Results 81 - 100 of 454
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Sep 2014, 11:17 am
Ever since the FDA decided that discretion was the better part of valor – or read the handwriting on the wall – and decided not to appeal United States v. [read post]
13 Mar 2020, 1:53 am by Sophie Corke
It can therefore serve as a form of prototype for other Member States, while also having its own characteristics such as a lack of a domestic pharmaceutical manufacturing industry and the effects of the single point of entry to a reimbursement system.Rochelle C. [read post]
6 Jul 2011, 1:19 pm by Venkat
The state statute very explicitly tried to make those meetings less useful to doctors by making the drug sales rep less well-prepared. [read post]
22 Sep 2016, 7:10 am
  As stated by Kitchin LJ in Medimmune Ltd v Novartis Pharmaceuticals UK Ltd [2012] EWCA Civ 1234:"Whether a route has a reasonable or fair prospect of success will depend upon all the circumstances including an ability rationally to predict a successful outcome, how long the project may take, the extent to which the field is unexplored, the complexity or otherwise of any necessary experiments, whether such experiments can be performed by routine means and… [read post]
8 May 2008, 12:22 pm
Wyeth Pharmaceuticals, 2008 WL 1821379 (5th Cir. [read post]
1 Nov 2017, 2:58 pm by Dennis Crouch
by Dennis Crouch The final group of amicus briefs were filed this past week in Oil States v. [read post]